Drug Shortage Report for LIPIDIL SUPRA

Last updated on 2018-01-11 History
Report ID 15035
Drug Identification Number 02241602
Brand name LIPIDIL SUPRA
Common or Proper name LIPIDIL SUPRA
Company Name BGP PHARMA ULC
Market Status MARKETED
Active Ingredient(s) FENOFIBRATE
Strength(s) 160MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 3x10
ATC code C10AB
ATC description LIPID MODIFYING AGENTS, PLAIN
Reason for shortage Requirements related to complying with good manufacturing practices.
Anticipated start date
Actual start date 2017-09-08
Estimated end date
Actual end date 2018-01-10
Shortage status Resolved
Updated date 2018-01-11
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 85 ADVANCE ROAD
ETOBICOKE, ONTARIO
CANADA M8Z 2S6
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v1 2017-07-10 English Compare
v2 2017-07-10 French Compare
v3 2017-07-24 English Compare
v4 2017-07-24 French Compare
v5 2017-08-10 English Compare
v6 2017-08-10 French Compare
v7 2017-08-29 English Compare
v8 2017-08-29 French Compare
v9 2017-09-02 English Compare
v10 2017-09-05 English Compare
v11 2017-09-05 French Compare
v12 2017-09-11 English Compare
v13 2017-09-11 French Compare
v14 2017-12-05 English Compare
v15 2017-12-05 French Compare
v16 2017-12-18 English Compare
v17 2017-12-18 French Compare
v18 2017-12-29 English Compare
v19 2017-12-29 French Compare
v20 2018-01-02 English Compare

Showing 1 to 20 of 26